US3138588A
(en)
|
1962-08-24 |
1964-06-23 |
American Home Prod |
17-ketals of estrone and derivatives thereof
|
US3433785A
(en)
|
1966-07-11 |
1969-03-18 |
Sterling Drug Inc |
15,16-disubstituted aromatic steroids,intermediates and processes
|
US5073374A
(en)
|
1988-11-30 |
1991-12-17 |
Schering Corporation |
Fast dissolving buccal tablet
|
US5340586A
(en)
|
1991-04-12 |
1994-08-23 |
University Of Southern California |
Methods and formulations for use in treating oophorectomized women
|
JPH07101977A
(ja)
|
1993-10-05 |
1995-04-18 |
Kureha Chem Ind Co Ltd |
ホルモン作用を軽減した新規なエストラジオール誘導体及びその増殖因子阻害剤
|
DE4344405C2
(de)
|
1993-12-24 |
1995-12-07 |
Marika Dr Med Ehrlich |
Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption
|
WO1997004752A1
(en)
|
1995-07-26 |
1997-02-13 |
Duramed Pharmaceuticals, Inc. |
Pharmaceutical compositions of conjugated estrogens and methods for their use
|
US6117446A
(en)
|
1999-01-26 |
2000-09-12 |
Place; Virgil A. |
Drug dosage unit for buccal administration of steroidal active agents
|
TW548277B
(en)
|
1999-07-16 |
2003-08-21 |
Akzo Nobel Nv |
Orally active androgens
|
PL202999B1
(pl)
|
1999-12-02 |
2009-08-31 |
Organon Nv |
Androgeny zawierające pierścień cyklopropanowy w pozycjach 14, 15 i zastosowanie takich androgenów
|
US20020132801A1
(en)
|
2001-01-11 |
2002-09-19 |
Schering Aktiengesellschaft |
Drospirenone for hormone replacement therapy
|
EP1216713A1
(en)
|
2000-12-20 |
2002-06-26 |
Schering Aktiengesellschaft |
Compositions of estrogen-cyclodextrin complexes
|
WO2002094276A1
(en)
|
2001-05-18 |
2002-11-28 |
Pantarhei Bioscience B.V. |
Pharmaceutical composition for use in hormone replacement therapy
|
EP1260225A1
(en)
|
2001-05-18 |
2002-11-27 |
Pantarhei Bioscience B.V. |
A pharmaceutical composition for use in hormone replacement therapy
|
CA2448278C
(en)
|
2001-05-23 |
2010-06-08 |
Christian Franz Holinka |
Drug delivery system comprising a tetrahidroxilated estrogen for use in hormonal contraception
|
WO2002094278A1
(en)
*
|
2001-05-23 |
2002-11-28 |
Pantarhei Bioscience B.V. |
Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
|
WO2003018026A1
(en)
|
2001-08-31 |
2003-03-06 |
Pantarhei Bioscience B.V. |
Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
|
ES2278925T3
(es)
|
2001-11-15 |
2007-08-16 |
Pantarhei Bioscience B.V. |
Uso de compuestos estrogenicos en combinacion con compuestos progestogenicos en terapias de sustitucion hormonal.
|
US6723348B2
(en)
|
2001-11-16 |
2004-04-20 |
Ethypharm |
Orodispersible tablets containing fexofenadine
|
HU227198B1
(en)
|
2001-11-27 |
2010-10-28 |
Richter Gedeon Nyrt |
Pharmaceutical composition for emergency contraception containing levonorgestrel
|
ES2274107T3
(es)
|
2002-02-21 |
2007-05-16 |
Bayer Schering Pharma Ag |
Composiciones farmaceuticas comprendiendo uno o mas esterioides, uno o mas componentes de tetrahidrofolato vitamina b12.
|
US20050147670A1
(en)
|
2002-05-29 |
2005-07-07 |
Impax Laboratories Inc. |
Oral disintegrating dosage forms
|
ES2399423T3
(es)
|
2002-06-11 |
2013-04-01 |
Pantarhei Bioscience B.V. |
Método para tratar la piel humana y una composición para el cuidado de la piel para su uso en tal método
|
ES2274252T3
(es)
|
2002-06-11 |
2007-05-16 |
Pantarhei Bioscience B.V. |
Metodo de tratamiento o prevencion de desordenes de medicion inmune y formulacion farmaceutica para su uso en ellos.
|
WO2004006936A1
(en)
|
2002-07-12 |
2004-01-22 |
Pantarhei Biosciences B.V. |
Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy
|
CA2495330A1
(en)
|
2002-08-28 |
2004-03-11 |
Robert Casper |
Estrogen replacement regimen
|
CA2503549C
(en)
|
2002-10-23 |
2012-07-10 |
Pantarhei Bioscience B.V. |
Pharmaceutical compositions comprising estetrol derivatives for use in cancer therapy
|
PT1558265E
(pt)
|
2002-11-05 |
2010-03-22 |
Bayer Schering Pharma Ag |
Utilização da drospirenona para o tratamento da hipertensão
|
EP1562976B1
(en)
|
2002-11-08 |
2010-05-26 |
Pantarhei Bioscience B.V. |
Synthesis of estetrol via estrone derived steroids
|
ATE340580T1
(de)
|
2003-05-22 |
2006-10-15 |
Pantarhei Bioscience Bv |
Verwendung von zusammensetzungen enthaltend ein oestrogen zur behandlung und verhinderung von muskelskelettschmerzen
|
ES2933479T3
(es)
|
2003-09-29 |
2023-02-09 |
Novo Nordisk Healthcare Ag |
Estabilidad mejorada de formulaciones de progestágenos
|
ES2482104T3
(es)
|
2003-09-29 |
2014-08-01 |
Novo Nordisk Femcare Ag |
Formulaciones HRT
|
EP1535618A1
(en)
|
2003-11-26 |
2005-06-01 |
Schering Aktiengesellschaft |
Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions
|
CN1557291A
(zh)
*
|
2004-01-14 |
2004-12-29 |
杨喜鸿 |
那格列奈分散片及其制备方法
|
MY151322A
(en)
|
2004-04-30 |
2014-05-15 |
Bayer Ip Gmbh |
Management of breakthrough bleeding in extended hormonal contraceptive regimens
|
GB0410616D0
(en)
|
2004-05-13 |
2004-06-16 |
Unilever Plc |
Antiperspirant or deodorant compositions
|
DE102004026670A1
(de)
|
2004-05-28 |
2005-12-15 |
Grünenthal GmbH |
Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
|
SI1755562T1
(sl)
|
2004-05-28 |
2014-02-28 |
Richter Gedeon Nyrt. |
Kontracepcijsko sredstvo, ki vsebuje folno kislino
|
UA89964C2
(ru)
|
2004-09-08 |
2010-03-25 |
Н.В. Органон |
15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
|
CN102796160A
(zh)
|
2005-05-26 |
2012-11-28 |
索尔瓦药物有限公司 |
17β-HSD1和STS抑制剂
|
US20070048369A1
(en)
|
2005-08-26 |
2007-03-01 |
National Starch And Chemical Investment Holding Corporation |
Mucosal delivery tablet
|
CA2636638C
(en)
|
2006-01-09 |
2014-02-18 |
Pantarhei Bioscience B.V. |
A method of treating an acute vascular disorder
|
WO2007106264A2
(en)
|
2006-03-02 |
2007-09-20 |
Warner Chilcott Company, Inc. |
Extended cycle multiphasic oral contraceptive method
|
CA2649361C
(en)
|
2006-06-08 |
2014-09-30 |
Warner Chilcott Company, Inc. |
Methods to administer solid dosage forms of ethinyl estradiol and prodrugs thereof with improved bioavailability
|
US20080113953A1
(en)
|
2006-06-08 |
2008-05-15 |
Warner Chilcott Company, Inc. |
Methods to administer solid dosage forms of ethinyl estradiol and prodrugs thereof with improved bioavailability
|
US20070286819A1
(en)
|
2006-06-08 |
2007-12-13 |
Warner Chilcott Company, Inc. |
Methods to administer ethinyl estradiol and prodrugs thereof with improved bioavailability
|
CN101489563A
(zh)
|
2006-07-06 |
2009-07-22 |
拜耳先灵医药股份有限公司 |
用于避孕和预防先天性畸形风险的药物制剂
|
DE112007001600A5
(de)
|
2006-07-06 |
2009-04-30 |
Bayer Schering Pharma Aktiengesellschaft |
Pharmazeutische Zusammensetzung zur Kontrazeption und zur Verminderung des Risikos angeborener Fehlbildungen
|
JP2010511062A
(ja)
|
2006-11-29 |
2010-04-08 |
ワイス エルエルシー |
エストロゲン/sermおよびエストロゲン/プロゲスチン二層錠剤
|
CA2674776A1
(en)
|
2006-12-20 |
2008-07-03 |
Duramed Pharmaceuticals, Inc. |
Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
|
EP2114412B1
(en)
|
2007-01-08 |
2010-07-14 |
Pantarhei Bioscience B.V. |
Method of treating or preventing infertility in a female mammal and pharmaceutical kit for use in such method
|
BRPI0806543A2
(pt)
|
2007-01-12 |
2014-04-22 |
Wyeth Corp |
Composições de comprimido em comprimido
|
EP2155205B1
(en)
|
2007-06-21 |
2011-12-21 |
Pantarhei Bioscience B.V. |
Treatment of meconium aspiration syndrome with estrogens
|
EP2170346B1
(en)
|
2007-07-19 |
2011-11-16 |
Pantarhei Bioscience B.V. |
Treatment or prevention of hypertensive disorders of pregnancy or fetal growth retardation
|
JP5399749B2
(ja)
*
|
2008-03-27 |
2014-01-29 |
沢井製薬株式会社 |
プロトンポンプ阻害剤を含有する被覆微粒子
|
WO2010033832A2
(en)
|
2008-09-19 |
2010-03-25 |
Evestra, Inc. |
Estriol formulations
|
DE102009007771B4
(de)
|
2009-02-05 |
2012-02-16 |
Bayer Schering Pharma Aktiengesellschaft |
Bukkales Applikationssystem, 17α-Estradiol enthaltend
|
EP3178476A1
(de)
|
2009-06-23 |
2017-06-14 |
Bayer Intellectual Property GmbH |
Pharmazeutische zusammensetzung und behandlungsverfahren zur notfallempfängnisverhütung
|
CN102058604A
(zh)
|
2009-11-17 |
2011-05-18 |
北京万全阳光医学技术有限公司 |
一种含有地诺孕素和戊酸***的药物组合物及其制备方法
|
BR112012026115B1
(pt)
|
2010-04-15 |
2019-12-24 |
Bayer Ip Gmbh |
forma de dosagem oral sólida, seu uso, e unidade de acondicionamento
|
US10849857B2
(en)
|
2010-07-28 |
2020-12-01 |
Laboratorios Leon Farma Sa |
Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
|
AR081670A1
(es)
|
2010-06-29 |
2012-10-10 |
Leon Farma Sa Lab |
Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
|
US9603860B2
(en)
|
2010-07-28 |
2017-03-28 |
Laboratorios Leon Farma Sa |
Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
|
WO2012055840A1
(en)
|
2010-10-28 |
2012-05-03 |
Bayer Pharma Aktiengesellschaft |
Composition and preparation for treatment of dysmenorrhea and menstrual pain and use of a hormonal agent and a zinc salt for treatment of menstrual disorders
|
JP2012240917A
(ja)
|
2011-05-16 |
2012-12-10 |
Zensei Yakuhin Kogyo Kk |
製剤化用微粒子とそれを含む製剤
|
MX342537B
(es)
|
2011-06-01 |
2016-10-04 |
Estetra Sprl |
Proceso para la produccion de intermediarios de estetrol.
|
MX341561B
(es)
|
2011-06-01 |
2016-08-25 |
Estetra Sprl |
Proceso para la produccion de intermediarios de estetrol.
|
EP2383279A1
(en)
|
2011-07-19 |
2011-11-02 |
Pantarhei Bioscience B.V. |
Process for the preparation of estetrol
|
US10179107B2
(en)
|
2011-07-19 |
2019-01-15 |
Pantarhei Bioscience B.V. |
Tablet containing dehydroepiandrosterone (DHEA)
|
EA028780B1
(ru)
|
2011-08-11 |
2017-12-29 |
Эстетра С.П.Р.Л. |
Применение эстетрола в качестве экстренного контрацептива
|
KR20140061438A
(ko)
|
2011-09-16 |
2014-05-21 |
훼링 비.브이. |
속용성 약학 조성물
|
HUE028963T2
(en)
|
2011-10-07 |
2017-01-30 |
Estetra Sprl |
Process for the preparation of estetrol
|
WO2013090117A1
(en)
|
2011-12-13 |
2013-06-20 |
Arstat, Inc. |
A multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogen
|
US9808470B2
(en)
|
2012-04-19 |
2017-11-07 |
Universite De Liege |
Estrogenic components for use in the treatment of neurological disorders
|
EP2653163A1
(en)
*
|
2012-04-19 |
2013-10-23 |
Université de Liège |
Estrogenic components for use in the treatment of neurological disorders
|
WO2014159377A1
(en)
|
2013-03-14 |
2014-10-02 |
Teva Women's Health, Inc. |
Compositions containing tanaproget and natural estrogens
|
JP6126456B2
(ja)
*
|
2013-05-17 |
2017-05-10 |
東和薬品株式会社 |
打錠用顆粒とその製造方法、その打錠用顆粒を用いた口腔内崩壊錠
|
JP2016520590A
(ja)
|
2013-05-21 |
2016-07-14 |
プレディクティヴ セラピューティクス, リミテッド ライアビリティー カンパニーPredictive Therapeutics, LLC |
治療薬および使用法
|
CA2924255C
(en)
|
2013-09-18 |
2022-11-22 |
Crystal Pharma, S.A.U. |
Process for the preparation of estetrol
|
EP3079671B1
(en)
|
2013-12-12 |
2017-10-25 |
Donesta Bioscience B.V. |
Orally disintegrating solid dosage unit containing an estetrol component
|
WO2016023009A1
(en)
|
2014-08-07 |
2016-02-11 |
Wake Forest University Health Sciences |
Compositions and methods for clearing a biological sample
|
WO2016053946A1
(en)
|
2014-09-29 |
2016-04-07 |
The Regents Of The University Of California |
Compositions and methods for maintaining cognitive function
|
US20180125860A1
(en)
|
2015-05-18 |
2018-05-10 |
Agile Therapeutics, Inc. |
Contraceptive Compositions and Methods for Improved Efficacy and Modulation of Side Effects
|
NO3106148T3
(pt)
|
2015-06-18 |
2018-08-11 |
|
|
GEP20217243B
(en)
|
2015-06-18 |
2021-04-26 |
Sprl Estetra |
Orodispersible dosage unit containing an estetrol component
|
HUE054551T2
(hu)
|
2015-06-18 |
2021-09-28 |
Estetra Sprl |
Ösztetrolt tartalmazó, szájban diszpergálódó tabletta
|
WO2016203009A1
(en)
|
2015-06-18 |
2016-12-22 |
Mithra Pharmaceuticals S.A. |
Orodispersible tablet containing estetrol
|
ES2970532T3
(es)
|
2015-06-23 |
2024-05-29 |
Laboratorios Leon Farma Sa |
Anticonceptivo basado en drospirenona para una paciente que presenta exceso de peso
|
KR20220144885A
(ko)
|
2016-08-05 |
2022-10-27 |
에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 |
월경통 및 생리통의 관리방법
|
US20200046729A1
(en)
|
2016-08-05 |
2020-02-13 |
Estetra Sprl |
Methods using combined oral contraceptive compositions with reduced cardiovascular effects
|
UY38075A
(es)
|
2018-02-07 |
2019-10-01 |
Estetra Sprl |
Composiciones anticonceptivas con efectos cardiovasculares reducidos
|